Intrathecal chemotherapy delivered by a lumbar-thecal catheter in metastatic medulloblastoma: a case illustration
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Background. Medulloblastoma is the most common malignant brain tumour in children. Despite recent advances, the prognosis in high risk patients remains poor. Further improvement in survival is dependent upon the development of strategies to attack the tumour more effectively, but with less toxicity. Intrathecal chemotherapy, is an ideal but currently underused method of directly targeting residual tumour within the area of resection and the leptomeningeal disease commonly associated with this tumour.
Method. We describe the case of a 12 yr old child with metastatic medulloblastoma, who received intrathecal topotecan via a spinal catheter.
Conclusion. This method represents a simple, safe and effective method of delivering an even and widespread distribution of drug within the cerebrospinal fluid (CSF) of the neuroaxis. With new agents being identified and others in the early stages of development, intrathecal chemotherapy may emerge as an important therapeutic option to consider when faced with such challenging cases.
- Conroy, S, Craven, I, Garnett, M, Barrat, S, Punt, J, Parker, T, Walker, DA (2004) An extensive review of chemotherapy agents suitable for intrathecal (IT) therapy in primitive neuro ectodermal tumour (PNET). Neuro-oncology 6: pp. 428
- Dunkel, IJ, Boyett, JM, Yates, A, Rosenblum, M, Garvin, JH, Bostrum, BC, Goldman, S, Sender, LS, Gardner, SL, Li, H, Allen, JC, Finlay, JL (1998) High dose carboplatin, thiotepa and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children’s cancer group. J Clin Oncol 16: pp. 222-228
- Gajjar, A, Chintagumpala, M, Ashley, D, Kellie, S, Kun, LE, Merchant, TE, Woo, S, Wheeler, G, Ahern, V, Krasin, MJ, Fouladi, M, Broniscer, A, Krance, R, Hale, GA, Stewart, CF, Dauser, R, Sanford, RA, Fuller, C, Lau, C, Boyett, JM, Wallace, D, Gilbertson, RJ (2006) Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long term results from a prospective, multicentre trial. Lancet Oncol 10: pp. 813-820 CrossRef
- Gammon, DC, Bhatt, MS, Tran, L, Van Horn, A, Benevenuti, M, Glantz, MJ (2006) Intrathecal topotecan in adult patients with neoplastic meningitis. Am J Health-Syst Pharm 63: pp. 2083-2086 CrossRef
- Kortmann, RD, Kuhl, J, Timmermann, B, Mittler, U, Urban, C, Budach, V, Richter, E, Willich, N, Flentje, M, Berthold, F, Slavc, I, Wolff, J, Meisner, C, Wiestler, O, Sorensen, N, Warmuth-Metz, M, Bamberg, M (2000) Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomised trial HIT’91. Int J Radiat Oncol Biol Phys 46: pp. 269-279 CrossRef
- Peris-Bonet, R, Martinez-Garcia, C, Lacour, B, Petrovich, S, Giner-Ripoll, B, Navajas, A, Steliarova-Foucher, E (2006) Childhood central nervous system tumours – incidence and survival in Europe (1978–1997): report from automated childhood cancer information system project. Eur J Cancer 42: pp. 2064-2080 CrossRef
- Rood, BR, MacDonald, TJ, Packer, RJ (2004) Current treatment of medulloblastoma: recent advances and future challenges. Sem Oncol 31: pp. 666-675 CrossRef
- Rutowski, S, Bode, U, Deinlein, F, Ottensmeier, H, Warmuth-Metz, M, Soerensen, N, Graf, N, Emser, A, Pietsch, T, Wolff, JE, Kortmann, RD, Kuehl, J (2005) Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352: pp. 978-986 CrossRef
- Stapleton, S, Blaney, S (2006) New agents for intrathecal adminstration. Cancer Invest 24: pp. 528-534 CrossRef
- Tarbell, NJ, Friedman, HS, Kepner, J, Barnes, P, Burger, P, Kun, LE (2000) Outcome for children with high stage medulloblastoma: results of the Paediatric Oncology Group 9031 study. Int J Radiat Oncol Biol Phys 48: pp. 179
- Taylor, RE, Bailey, CC, Robinson, K, Weston, CL, Ellison, D, Ironside, J, Lucraft, H, Gilbertson, R, Tait, DM, Walker, DA, Pizer, BL, Imeson, J, Lashford, LS (2003) Results of a randomised study of pre-radiation chemotherapy versus radiotherapy alone for non-metastatic (M0-1) medulloblastoma. The international society of Paediatric Oncology/United Kingdom children’s cancer study group PNET-3 study. J Clin Oncol 21: pp. 1581-1591 CrossRef
- Taylor, RE, Bailey, CC, Robinson, KJ, Weston, CL, Walker, DA, Ellison, D, Ironside, J, Pizer, BL, Lashford, LS (2005) Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer 41: pp. 727-734 CrossRef
- Verlooy, J, Mosseri, V, Bracard, S, Lellouch Tubiana, A, Kalifa, C, Pichon, F, Frappaz, D, Chastagner, P, Pagnier, A, Bertozzi, AI, Gentet, JC, Sariban, E, Rialland, X, Edan, C, Bours, D, Zerah, M, Le Gales, C, Alapetite, C, Doz, F (2006) Treatment of high risk medulloblastomas in children above the age of 3 years: A SFOP study. Eur J Cancer 42: pp. 3004-3014 CrossRef
- Intrathecal chemotherapy delivered by a lumbar-thecal catheter in metastatic medulloblastoma: a case illustration
Volume 150, Issue 7 , pp 709-712
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Keywords: Metastatic medulloblastoma; primitive neuroectodermal tumour; intrathecal chemotherapy; topotecan.
- Industry Sectors
- Author Affiliations
- A1. Queens Medical Centre, Department of Neurosurgery, University Hospital, Nottingham, UK
- A2. Queens Medical Centre, Children’s Brain Tumour Research Centre, Institute of Child Health, University of Nottingham Medical School, Nottingham, UK
- A3. Queens Medical Centre, Department of Neuroradiology, University Hospital, Nottingham, UK